Therefore, based on our data it can be hypothesized that in our population a combined mechanism represented by negative direct pancreatic effect of PAS-LAR combined with detrimental effects of high GH on insulin resistance may occur [40] although our data did not allow to clarify which of the two mechanisms could be cliinically prevalent in determining the observed metaboslic worsening. This evidence concerns the gene GH1 and Insulin resistance.